Related Experiment Video
Updated: Jan 20, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Detection of In Vivo Mutation in the Hprt and Pig-a Genes of Rat Lymphocytes
Vasily N Dobrovolsky1, Joseph G Shaddock2, Roberta A Mittelstaedt2
1Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, USA. Vasily.dobrovolsky@fda.hhs.gov.
Abstract:
Assays for in vivo mutation are used to identify genotoxic hazards and phenotypes prone to genomic instability and cancer. The hypoxanthine guanine phosphoribosyl transferase (Hprt) gene and the phosphatidyl inositol glycan, class A (Pig-a) gene are endogenous X-linked genes that can be used as reporters of mutation in peripheral blood lymphocytes from most mammals. Here we describe methodology for measuring Hprt and Pig-a mutation in rat T-lymphocytes. The identification and selective expansion of mutant lymphocytes is based upon the phenotypic properties of Hprt- and Pig-a-deficient cells, that is, resistance to the purine analog, 6-thioguanine, or to the bacterial toxin, proaerolysin. Expanded mutants can be further analyzed by sequencing cDNA from the target transcripts for identification of small sequence alterations and by multiplex PCR analysis of genomic DNA for the detection of deletions.
Related Concept Videos
Mutation, Gene Flow, and Genetic Drift
12:03Myocardial Infarction and Functional Outcome Assessment in Pigs
06:31Microscopic Observation of Lymphocyte Dynamics in Rat Peyer's Patches
07:08The Lambda Select cII Mutation Detection System
10:25Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System
04:34Digital Droplet Polymerase Chain Reaction for Indel Mutation Detection in Target Genes

